Home Applications 217603 Application 217603
Type NDA
Sponsor TARSUS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 XDEMVY LOTILANER SOLUTION/DROPS;OPHTHALMIC 0.25% Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217603-001 XDEMVY LOTILANER 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24
Orange Book patents# Current patent rows page 1 of 1 · 9 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217603-001 8383659 2030-01-17 Drug substance, Drug product 2023-08-23 N217603-001 10835517 2038-12-14 U-3674 2023-08-23 N217603-001 11197847 2038-12-14 U-3674 2023-08-23 N217603-001 11690826 2038-12-14 U-3674 2023-08-23 N217603-001 11690827 2038-12-14 U-3674 2023-08-23 N217603-001 11752137 2038-12-14 Drug product 2023-09-19 N217603-001 12171750 2038-12-14 U-3674 2025-01-23 N217603-001 12213964 2038-12-14 Drug product 2025-03-06 N217603-001 12364685 2038-12-14 Drug product 2025-08-07
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217603-001 NCE 2028-07-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217603-001 XDEMVY 0.25% SOLUTION/DROPS / OPHTHALMIC RLD, RS 2023-07-24 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 4 · 144 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N217603-001 8383659 2030-01-17 Drug substance, Drug product 2023-08-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217603-001 10835517 2038-12-14 U-3674 2023-08-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217603-001 11197847 2038-12-14 U-3674 2023-08-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217603-001 11690826 2038-12-14 U-3674 2023-08-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217603-001 11690827 2038-12-14 U-3674 2023-08-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217603-001 11752137 2038-12-14 Drug product 2023-09-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217603-001 12171750 2038-12-14 U-3674 2025-01-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217603-001 12213964 2038-12-14 Drug product 2025-03-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217603-001 12364685 2038-12-14 Drug product 2025-08-07 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217603-001 8383659 2030-01-17 Drug substance, Drug product 2023-08-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217603-001 10835517 2038-12-14 U-3674 2023-08-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217603-001 11197847 2038-12-14 U-3674 2023-08-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217603-001 11690826 2038-12-14 U-3674 2023-08-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217603-001 11690827 2038-12-14 U-3674 2023-08-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217603-001 11752137 2038-12-14 Drug product 2023-09-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217603-001 12171750 2038-12-14 U-3674 2025-01-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217603-001 12213964 2038-12-14 Drug product 2025-03-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217603-001 12364685 2038-12-14 Drug product 2025-08-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 8383659 2030-01-17 Drug substance, Drug product 2023-08-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 10835517 2038-12-14 U-3674 2023-08-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 11197847 2038-12-14 U-3674 2023-08-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 11690826 2038-12-14 U-3674 2023-08-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 11690827 2038-12-14 U-3674 2023-08-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 11752137 2038-12-14 Drug product 2023-09-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 12171750 2038-12-14 U-3674 2025-01-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 12213964 2038-12-14 Drug product 2025-03-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217603-001 12364685 2038-12-14 Drug product 2025-08-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217603-001 8383659 2030-01-17 Drug substance, Drug product 2023-08-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217603-001 10835517 2038-12-14 U-3674 2023-08-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217603-001 11197847 2038-12-14 U-3674 2023-08-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217603-001 11690826 2038-12-14 U-3674 2023-08-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217603-001 11690827 2038-12-14 U-3674 2023-08-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217603-001 11752137 2038-12-14 Drug product 2023-09-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217603-001 12171750 2038-12-14 U-3674 2025-01-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217603-001 12213964 2038-12-14 Drug product 2025-03-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217603-001 12364685 2038-12-14 Drug product 2025-08-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217603-001 8383659 2030-01-17 Drug substance, Drug product 2023-08-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217603-001 10835517 2038-12-14 U-3674 2023-08-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217603-001 11197847 2038-12-14 U-3674 2023-08-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217603-001 11690826 2038-12-14 U-3674 2023-08-23 fd3edfee7708…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join XDEMVY LOTILANER OPHTHALMIC SOLUTION Tarsus Pharmaceuticals, Inc. ccd9e37c-654e-4e84-8c85-6523457df979 2024-08-10 Warnings, Adverse reactions Exact identifier application applno (NDA): 217603 application number: NDA217603
Documents# Document, Submission type, Date table Document Submission type Date 75114 ORIG 2023-08-18 74897 ORIG 2023-07-26 74889 ORIG 2023-07-25